Search form

Search form

In a meta-analysis of seven studies, Chinese researchers found that women with high-level coffee consumption during their pregnancy were more likely than women with little to no consumption to have children with acute lymphoblastic leukemia or acute myeloid leukemia. The findings appear in the American Journal of Obstetrics & Gynecology.

Related Summaries

A meta-analysis of 21 studies revealed that children of Asian descent with the single-nucleotide polymorphism XRCC1 Arg399Gin are more likely to develop acute lymphocytic leukemia than others with the polymorphism. The study in the journal OncoTargets and Therapy found no link between the SNP and chronic myeloid leukemia or chronic lymphocytic leukemia among white children.

A meta-analysis involving 3,325 patients who participated in five randomized controlled trials found that adding gemtuzumab ozogamicin, or Mylotarg, to induction chemotherapy was associated with improved survival and lower relapse risk in certain patients with acute myeloid leukemia, compared with chemotherapy alone. The study was reported in The Lancet Oncology. The drug was pulled from the market over safety concerns in 2010, 10 years after it was approved in the U.S., but experts say it is beneficial for patients with certain characteristics and warrants reconsideration.

ERYtech Pharma granted Recordati the rights to sell Graspa, an experimental drug for leukemia, in Europe. The drug, a formulation of L-asparaginase, is being evaluated in a Phase II/III study for acute lymphoblastic leukemia and will soon enter a midstage trial for acute myeloid leukemia. Graspa has orphan-drug status for acute lymphoblastic leukemia in the U.S. and Europe.